Comparison of vasculoprotective effect of angiotensin receptor blocker, candesartan and diuretics in patients with essential hypertension

被引：0
|
作者：
Yamakado, M
Ishizaka, Y
Maehata, E
机构：
[1] Mitsui Mem Hosp, Dept Hlth Care, Chiyoda Ku, Tokyo 101, Japan
[2] Mitsui Mem Hosp, Cent Clin Lab, Chiyoda Ku, Tokyo 101, Japan
来源：
AMERICAN JOURNAL OF HYPERTENSION | 2003年 / 16卷 / 05期
关键词：
vasculoprotection; angiotensin recepter blocker; oxidative stress;
D O I：
10.1016/S0895-7061(03)00433-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P268
引用
收藏
页码：134A / 134A
页数：1
相关论文
共 50 条
  • [1] Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension
    Ghiadoni, L
    Virdis, A
    Magagna, A
    Taddei, S
    Salvetti, A
    HYPERTENSION, 2000, 35 (01) : 501 - 506
  • [2] Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension
    Skurk, T
    Lee, YM
    Nicuta-Rölfs, TO
    Haastert, B
    Wirth, A
    Hauner, H
    DIABETES OBESITY & METABOLISM, 2004, 6 (01): : 56 - 62
  • [3] Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension
    Canzanello, Vincent J.
    Baranco-Pryor, Evelyn
    Rahbari-Oskoui, Frederic
    Schwartz, Gary L.
    Boerwinkle, Eric
    Turner, Stephen T.
    Chapman, Arlene B.
    AMERICAN JOURNAL OF HYPERTENSION, 2008, 21 (01) : 61 - 66
  • [4] Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension
    Sasamura, Hiroyuki
    Kitamura, Yudai
    Nakamura, Mari
    Ryuzaki, Munekazu
    Saruta, Takao
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2006, 28 (05) : 511 - 520
  • [5] Effects of the angiotensin receptor blocker (ARB) candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertension
    Sasamura, Hiroyuki
    Kitamura, Yudai
    Nakamura, Mari
    Ryuzaki, Munekazu
    Saruta, Takao
    JOURNAL OF HYPERTENSION, 2006, 24 : 298 - 298
  • [6] Improvement of renal function by angiotensin II receptor blocker in patients with essential hypertension
    Watanabe, S
    Okura, T
    Takata, Y
    Miyoshi, K
    Higaki, J
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (05) : 103A - 103A
  • [7] Angiotensin II receptor blocker: Candesartan cilexetil
    Inada, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 35P - 35P
  • [8] Candesartan cilexetil: An angiotensin II receptor blocker
    Stoukides, CA
    McVoy, HJ
    Kaul, AF
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) : 1287 - 1298
  • [9] Angiotensin receptor blockade in hypertension: A comparison between Losartan and Candesartan
    Woittiez, AJJ
    Prins, A
    Roelofsen, WJ
    Van Bergeijk, LJ
    JOURNAL OF HYPERTENSION, 2000, 18 : S210 - S210
  • [10] Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension
    Higashiura, K
    Ura, N
    Miyazaki, Y
    Shimamoto, K
    JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (Suppl 1) : S71 - S74
12345